Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret K Hahn

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Nature Metabolism|March 21, 2025
GLP-2 attenuates antipsychotics' adverse metabolic effectsSandra Pereira, Margaret K Hahn
Schizophrenia Bulletin|May 12, 2020
Mortality Risk Following Acute Coronary Syndrome Among Patients With Schizophrenia Spectrum Disorders-Addressing the GapsMargaret K Hahn, Roshni Panda
The Journal of Endocrinology|January 10, 2024
In vivo techniques for assessment of insulin sensitivity and glucose metabolismMargaret K Hahn, Adria Giacca, Sandra Pereira
The Annals of Pharmacotherapy|July 1, 2010
Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gainMargaret K Hahn, Tony Cohn, Gary Remington
Clinical Schizophrenia & Related Psychoses|January 11, 2013
Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parametersMargaret K Hahn, Tony Cohn, Celine Teo, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effectsMargaret K Hahn, Gary Remington, Daniel Bois, et al.
Psychoneuroendocrinology|February 26, 2019
Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neuronsChantel Kowalchuk, Pruntha Kanagasundaram, Denise D Belsham, et al.
Neuroscience and Biobehavioral Reviews|October 25, 2016
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studiesDavide Amato, Clare L Beasley, Margaret K Hahn, et al.
Frontiers in Psychiatry|October 15, 2021
Editorial: Cardiovascular and Physical Health in Severe Mental IllnessSri Mahavir Agarwal, Anthony Christopher Vernon, Ganesan Venkatasubramanian, et al.
Journal of Clinical Psychopharmacology|November 17, 2022
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case SeriesNicolette Stogios, Margaret K Hahn, Yona Lunsky, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Nature Metabolism|March 21, 2025
GLP-2 attenuates antipsychotics' adverse metabolic effectsSandra Pereira, Margaret K Hahn
Schizophrenia Bulletin|May 12, 2020
Mortality Risk Following Acute Coronary Syndrome Among Patients With Schizophrenia Spectrum Disorders-Addressing the GapsMargaret K Hahn, Roshni Panda
The Journal of Endocrinology|January 10, 2024
In vivo techniques for assessment of insulin sensitivity and glucose metabolismMargaret K Hahn, Adria Giacca, Sandra Pereira
The Annals of Pharmacotherapy|July 1, 2010
Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gainMargaret K Hahn, Tony Cohn, Gary Remington
Clinical Schizophrenia & Related Psychoses|January 11, 2013
Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parametersMargaret K Hahn, Tony Cohn, Celine Teo, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effectsMargaret K Hahn, Gary Remington, Daniel Bois, et al.
Psychoneuroendocrinology|February 26, 2019
Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neuronsChantel Kowalchuk, Pruntha Kanagasundaram, Denise D Belsham, et al.
Neuroscience and Biobehavioral Reviews|October 25, 2016
Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studiesDavide Amato, Clare L Beasley, Margaret K Hahn, et al.
Frontiers in Psychiatry|October 15, 2021
Editorial: Cardiovascular and Physical Health in Severe Mental IllnessSri Mahavir Agarwal, Anthony Christopher Vernon, Ganesan Venkatasubramanian, et al.
Journal of Clinical Psychopharmacology|November 17, 2022
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case SeriesNicolette Stogios, Margaret K Hahn, Yona Lunsky, et al.
Pageof 9